RevMed
Home/Other/Acid, Hyaluronic, Intraarticular/DUROLANE

BIOVENTUS LLC 1082020 DUROLANE

Company Name
BIOVENTUS LLC
Catalog Number
1082020

Description

DUROLANE is a clear, transparent, viscous gel of highly purified, stabilized, non-animal-derived sodium hyaluronate that is biosynthesized using bacterial fermentation. NASHA® technology is used to stabilize naturally entangled hyaluronic acid (HA) chains to produce a gel. The gel is suspended in phosphate-buffered saline at a concentration of 20 mg/mL. DUROLANE is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen.
Have questions, or need more information? Contact Us

Pricing
Summary

Price Not Available
Out of Stock
Interested in this product?
Contact us or login to add to your watchlist.

Related Items

89122-4966-30

FIDIA FARMACEUTICI SPA 89122-4966-30 Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe

HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen).
Out of Stock
Other
89122-0496-63

FIDIA FARMACEUTICI SPA 89122-0496-63 Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe

HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals.
Out of Stock
Other
89122-0724-12

FIDIA FARMACEUTICI SPA 89122-0724-12 Hyalgan® Sodium Hyaluronate 2mL Vial

Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL vial is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. It is a viscous solution of purified natural Sodium Hylauronate (Hyalectin®) in buffered physiological sodium chloride. The sodium hylauronate is extracted from rooster combs. It is given by intra-articular injection in a treatment cycle consisting of five injections given at weekly intervals. Some patients may experience benefit with three injections given at weekly cycles. This has been noted in studies reported in the literature in which patients treated with three injections were followed for 60 days.
Out of Stock
Other

Additional Details

Device Identifier
00816986020808
Is RX
Yes
Is Over the Counter
No
Requires Sterilization
No
Is Sterile
Yes
Is Single Use
Yes

Categories

Barcode Mapping

Unit of MeasurementEachesGTIN
Each100816986020808
Each189130-2020-1
Case of 545410816986020805